The following is a continuation of all our recent MindMed coverage.

Over the past few weeks, we published a few conversations with Jake Freeman.

Click here to watch part 1 of the Jake Freeman interview.

Click here to watch part 2 of the Jake Freeman interview.

Before that, it all began with a two-part interview with Dr. Scott Freeman in August.

Click here to watch part 1 of the interview.

Click here to watch part 2 of the interview.

Click here to see the prior installment of The MindMed Chronicles

A Conversation with the MindMed CEO, Robert Barrow

While we’ve had the pleasure of speaking with Freeman Captial on multiple occasions, we are just as excited to be joined by MindMed’s CEO, Robert Barrow, to help readers better understand their side of the story. This interview with Robert is only the beginning. We fully expect to have him back on again soon.

We hope you enjoy this interview with Robert Barrow of MindMed ($MNMD).

Stay Tuned for More

We expect to have Rob and others involved in this story back on to continue the narrative. Stick around for more interviews, in-depth analyses, and insights as the story progresses.

Follow the Psychedelic Invest YouTube Channel

As always, please like and subscribe to the Psychedelic Invest YouTube channel.